NASDAQ: KNSA · Health Care / Biotechnology: Pharmaceutical Preparations

Kiniksa Pharmaceuticals International plc

How Kiniksa Pharmaceuticals International plc compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$7.7B

Price

$97.56

P/E

75.6

EPS (TTM)

$1.29

1-year return

161.0%

Dividend yield

0.0%

52-week range

$41.49–$97.56

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources